144 related articles for article (PubMed ID: 23768859)
1. [Thromboprophylaxis in medical ill patients from Emergency Department].
Ruiz Artacho P; Merlo Loranca M; Jiménez Hernández S
Med Clin (Barc); 2013 Nov; 141(9):415. PubMed ID: 23768859
[No Abstract] [Full Text] [Related]
2. [Adequation of thromboprophylaxis during former admission in patients attended in emergencies with thromboembolic disease].
Ruiz-Artacho P; Pérez Peña C; Iriarte A; Martín-Sánchez FJ
Med Clin (Barc); 2013 Aug; 141(3):130-1. PubMed ID: 23433664
[No Abstract] [Full Text] [Related]
3. The inefficacy of enoxaparin prophylaxis in a patient with congenital antithrombin deficiency.
Tomkowski WZ; Dybowska M; Kuca P; Gralec R; Burakowski J
Clin Appl Thromb Hemost; 2009; 15(2):241. PubMed ID: 19357104
[No Abstract] [Full Text] [Related]
4. Choosing a parenteral anticoagulant agent.
Diuguid DL
N Engl J Med; 2001 Nov; 345(18):1340-2. PubMed ID: 11794155
[No Abstract] [Full Text] [Related]
5. [Assessment of venous thromboembolism risk in hospitalized medical patients. Concordance between PRETEMED guide and the recommendations of the viii conference of the American College of Chest Physicians].
Gallardo Jiménez P; Guijarro Merino R; Vallejo Herrera V; Sánchez Morales D; Villalobos Sánchez A; Perelló González-Moreno JI; Gómez-Huelgas R
Med Clin (Barc); 2012 Nov; 139(11):467-72. PubMed ID: 22032816
[TBL] [Abstract][Full Text] [Related]
6. Selecting an agent for prophylaxis of venous thromboembolism.
Myers J
Am J Health Syst Pharm; 2006 Dec; 63(24):2448-50. PubMed ID: 17158692
[No Abstract] [Full Text] [Related]
7. Thromboprophylaxis in knee arthroscopy patients: revisiting values and preferences.
Hull RD
Ann Intern Med; 2008 Jul; 149(2):137-9. PubMed ID: 18626053
[No Abstract] [Full Text] [Related]
8. [Thromboembolisms endanger the internist patients, too: who needs heparin].
Bischoff A
MMW Fortschr Med; 2006 Mar; 148(11):21-2. PubMed ID: 16612959
[No Abstract] [Full Text] [Related]
9. Extended Thromboprophylaxis for Medical Patients.
Dalen JE; Stein PD; Plitt JL; Jaswal N; Alpert JS
Am J Med; 2020 Jan; 133(1):9-11. PubMed ID: 31247174
[No Abstract] [Full Text] [Related]
10. [The treatment of deep venous thrombosis using low-molecular heparin. Swiss Consensus Conference for the Application of Low-molecular Heparin].
Bachmann F
Schweiz Med Wochenschr; 1994 Feb; 124(5):169-78. PubMed ID: 8128198
[No Abstract] [Full Text] [Related]
11. [Low-molecular weight heparins in the prophylaxis and treatment of pulmonary thromboembolism].
Borja J; Olivella P
Rev Esp Cardiol; 2001 Sep; 54(9):1121-2. PubMed ID: 11535193
[No Abstract] [Full Text] [Related]
12. Is low-molecular-weight heparin suitable in all patients undergoing knee arthroplasty?
Geerts W
Ann Intern Med; 2008 Nov; 149(9):687; author reply 687-8. PubMed ID: 18981493
[No Abstract] [Full Text] [Related]
13. A pilot retrospective comparison of fondaparinux and enoxaparin for the prevention of venous thromboembolism (VTE) in patients with stroke.
Mukand JA; Mukand NH
Med Health R I; 2010 Nov; 93(11):349-53. PubMed ID: 21155516
[No Abstract] [Full Text] [Related]
14. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
[TBL] [Abstract][Full Text] [Related]
15. Prevention of venous thromboembolism.
Geerts WH; Heit JA; Clagett GP; Pineo GF; Colwell CW; Anderson FA; Wheeler HB
Chest; 2001 Jan; 119(1 Suppl):132S-175S. PubMed ID: 11157647
[No Abstract] [Full Text] [Related]
16. Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism.
Goldhaber SZ; Fanikos J
Circulation; 2004 Oct; 110(16):e445-7. PubMed ID: 15492324
[No Abstract] [Full Text] [Related]
17. Overview of enoxaparin in the treatment of deep vein thrombosis.
Deitcher SR
Am J Manag Care; 2000 Nov; 6(20 Suppl):S1026-33. PubMed ID: 11484302
[TBL] [Abstract][Full Text] [Related]
18. [Evidence for thrombosis prophylaxis to high-risk patients].
Själander A; Jansson JH; Bergqvist D; Eriksson H; Svensson P
Lakartidningen; 2007 May 14-29; 104(20-21):1585-7. PubMed ID: 17564265
[No Abstract] [Full Text] [Related]
19. The evolution and impact of the American College of Chest Physicians consensus statement on antithrombotic therapy.
Tapson VF
Clin Chest Med; 2003 Mar; 24(1):139-51, vii. PubMed ID: 12685061
[TBL] [Abstract][Full Text] [Related]
20. Prevention of venous thromboembolism with fondaparinux.
Priestley M
N Engl J Med; 2002 Mar; 346(12):940-2; author reply 940-2. PubMed ID: 11911134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
